Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126035963 | 12603596 | 3 | F | 20151106 | 20160728 | 20160728 | EXP | ES-KALEO, INC-2015SA180482 | KALEO | PUENTE YM, DAZA JC, GENTIL A, MONTESEIRIN FJ. CASE REPORT: ACUTE MYOCARDIAL INFARCTION DUE TO SEVERE ANGIOEDEMA. 34TH CONGRESS OF THE EUROPEAN ACADEMY OF ALLERGY AND CLINICAL IMMUNOLOGY; 2015 JUN 06-10; BARCELONA, SPAIN. ALLERGY EUR J ALLERGY CLIN IMMUNOL. 2015 SEP;70(SUPPL 101):472. DOI: 10.1111/ALL.12720. | 40.00 | YR | F | Y | 0.00000 | 20160728 | OT | ES | ES |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126035963 | 12603596 | 1 | PS | EPINEPHRINE. | EPINEPHRINE | 1 | Unknown | AMPOULE | UNK | 201739 | .3 | ML | |||||||
| 126035963 | 12603596 | 2 | SS | EPINEPHRINE. | EPINEPHRINE | 1 | Unknown | 5 DOSES. | UNK | 201739 | |||||||||
| 126035963 | 12603596 | 3 | SS | DANAZOL. | DANAZOL | 1 | Unknown | UNK | 0 | ||||||||||
| 126035963 | 12603596 | 4 | C | MONTELUKAST | MONTELUKAST SODIUM | 1 | 0 | ||||||||||||
| 126035963 | 12603596 | 5 | C | TRANEXAMIC ACID. | TRANEXAMIC ACID | 1 | 0 | ||||||||||||
| 126035963 | 12603596 | 6 | C | LEVOTHYROXINE. | LEVOTHYROXINE | 1 | 0 | ||||||||||||
| 126035963 | 12603596 | 7 | C | PREDNISONE. | PREDNISONE | 1 | 0 | ||||||||||||
| 126035963 | 12603596 | 8 | C | METHOTREXATE. | METHOTREXATE | 1 | 0 | ||||||||||||
| 126035963 | 12603596 | 9 | C | METHYLPREDNISOLONE. | METHYLPREDNISOLONE | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126035963 | 12603596 | 1 | Angioedema |
| 126035963 | 12603596 | 3 | Angioedema |
| 126035963 | 12603596 | 4 | Angioedema |
| 126035963 | 12603596 | 5 | Angioedema |
| 126035963 | 12603596 | 6 | Angioedema |
| 126035963 | 12603596 | 7 | Angioedema |
| 126035963 | 12603596 | 8 | Angioedema |
| 126035963 | 12603596 | 9 | Angioedema |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126035963 | 12603596 | HO |
| 126035963 | 12603596 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126035963 | 12603596 | Chest pain | |
| 126035963 | 12603596 | Myocardial infarction | |
| 126035963 | 12603596 | Sinus tachycardia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |